{
    "organizations": [],
    "uuid": "a59797924263dcc539b6ca3fbaf14ec78110e6a6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amag-pharmaceuticals-announces-fda/brief-amag-pharmaceuticals-announces-fda-approval-of-supplemental-new-drug-application-for-feraheme-idUSASB0C3XN",
    "ord_in_thread": 0,
    "title": "BRIEF-AMAG Pharmaceuticals Announces FDA Approval Of Supplemental New Drug Application (SNDA) For Feraheme",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - Amag Pharmaceuticals Inc:\n* AMAG PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR FERAHEMEÂ® (FERUMOXYTOL INJECTION) Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-05T21:27:00.000+02:00",
    "crawled": "2018-02-07T00:01:53.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "amag",
        "pharmaceutical",
        "inc",
        "amag",
        "pharmaceutical",
        "announces",
        "fda",
        "approval",
        "supplemental",
        "new",
        "drug",
        "application",
        "snda",
        "ferumoxytol",
        "injection",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}